港股異動丨藥明生物九連漲 股價創歷史新高 今日起全面復工
格隆匯2月12日丨藥明生物(2269.HK)漲約3%,報114.6港元,股價刷新歷史新高,且有望實現九連漲,總市值達到1487億港元。

即日起,藥明生物位於無錫、上海和蘇州的三大運營基地將全面有序復工。藥明生物未在武漢建立運營基地,也未有來自武漢的主要供應商,因此公司研發和生產所需的相關物料供應未受影響。樣品和物料運輸、進出口及清關工作均正常進行。基於強大的GMP質量體系和穩健的全球供應鏈,公司預計不會看到疫情對其GMP生產運營產生任何負面影響。
此外,藥明生物目前已動員超過240位科學家組建起一支大規模專項攻關技術團隊,並與國內外企業密切合作賦能開發、生產多個新型冠狀病毒中和抗體,精準阻擊疫情。這些中和抗體的體外療效試驗數據預計下月完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.